| http://www.w3.org/ns/prov#value | - Based on these findings, the U.S. Food and Drug Administration approved Lucentis for the treatment of diabetic macular edema.The Action to Control Cardiovascular Risk in Diabetes Eye Study, sponsored in part by the NEI, showed that intensive control of blood glucose and blood lipids, including cholesterol, slows the progression of diabetic retinopathy.Through its National Eye Health Education Prog
|
